JP2014512403A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512403A5
JP2014512403A5 JP2014506862A JP2014506862A JP2014512403A5 JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5 JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5
Authority
JP
Japan
Prior art keywords
composition
collagen
weight
total weight
monosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506862A
Other languages
English (en)
Japanese (ja)
Other versions
JP6050320B2 (ja
JP2014512403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/057647 external-priority patent/WO2012146655A1/en
Publication of JP2014512403A publication Critical patent/JP2014512403A/ja
Publication of JP2014512403A5 publication Critical patent/JP2014512403A5/ja
Application granted granted Critical
Publication of JP6050320B2 publication Critical patent/JP6050320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506862A 2011-04-27 2012-04-26 止血組成物 Active JP6050320B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161517973P 2011-04-27 2011-04-27
EP11305492.8 2011-04-27
EP11305492 2011-04-27
US61/517,973 2011-04-27
PCT/EP2012/057647 WO2012146655A1 (en) 2011-04-27 2012-04-26 Hemostatic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016228298A Division JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Publications (3)

Publication Number Publication Date
JP2014512403A JP2014512403A (ja) 2014-05-22
JP2014512403A5 true JP2014512403A5 (cg-RX-API-DMAC7.html) 2015-06-18
JP6050320B2 JP6050320B2 (ja) 2016-12-21

Family

ID=46022222

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014506862A Active JP6050320B2 (ja) 2011-04-27 2012-04-26 止血組成物
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Country Status (15)

Country Link
US (6) US9283187B2 (cg-RX-API-DMAC7.html)
EP (3) EP2701729B1 (cg-RX-API-DMAC7.html)
JP (2) JP6050320B2 (cg-RX-API-DMAC7.html)
CN (2) CN106390186B (cg-RX-API-DMAC7.html)
AU (4) AU2012247480B2 (cg-RX-API-DMAC7.html)
BR (2) BR112013027567B1 (cg-RX-API-DMAC7.html)
CA (2) CA3108894A1 (cg-RX-API-DMAC7.html)
CY (1) CY1122251T1 (cg-RX-API-DMAC7.html)
DK (1) DK3513803T3 (cg-RX-API-DMAC7.html)
ES (1) ES2882911T3 (cg-RX-API-DMAC7.html)
PL (2) PL3513803T3 (cg-RX-API-DMAC7.html)
RS (1) RS59243B1 (cg-RX-API-DMAC7.html)
SI (1) SI2701729T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900467T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012146655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
SMT201900467T1 (it) 2011-04-27 2019-09-09 Biomup Composizioni emostatiche
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US20160193381A1 (en) * 2015-01-06 2016-07-07 St. Teresa Medical, Inc. Hemostatic products
US10080728B2 (en) 2015-01-20 2018-09-25 Viktor Veniaminovich Tets Hemostatic agent
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
ES2882506T3 (es) 2016-08-12 2021-12-02 Biomup France Sas Fluido hemostático
WO2018217743A1 (en) 2017-05-24 2018-11-29 Viktor Veniaminovich Tets Fractionated antimicrobial compositions and use thereof
WO2019089717A1 (en) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Fibrin sealant products
BR112020016593B1 (pt) * 2018-02-15 2023-11-14 Biom'up France SAS Produto hemostático impresso, uso de fluido hemostático e método de fabricação de produtos hemostáticos
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
CN110652648B (zh) * 2018-08-01 2021-05-28 浙江探针生物科技有限公司 输送药剂的器件及其装置和组件
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US11027041B2 (en) * 2019-06-30 2021-06-08 James Drake Stable and robust blended hemostatic composition
JP7550390B2 (ja) 2020-05-08 2024-09-13 国立大学法人 東京大学 止血用ポリマー材料キット
KR102521769B1 (ko) * 2020-07-20 2023-04-14 주식회사 테라시온바이오메디칼 국소 지혈 파우더 조성물 및 이의 제조방법
EP4580751A2 (en) 2022-09-29 2025-07-09 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13810T1 (de) 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4942153A (en) 1987-02-03 1990-07-17 Fernandez Helen M Skin moisturizing product and process
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
IT1263394B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
DE19520575A1 (de) 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
CA2295247C (en) 1997-06-18 2009-05-26 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
ATE343379T1 (de) 1998-08-20 2006-11-15 3M Innovative Properties Co Sprühverband und wirkstoffabgabesystem
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
AT411326B (de) 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
AT412445B (de) * 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
US20030003157A1 (en) * 2001-06-06 2003-01-02 University Of Medicine & Dentistry Of New Jersey Collagen compositions and methods for making and using the same
US6613348B1 (en) * 2001-07-31 2003-09-02 Manoj K. Jain Process of controlling absorbency in collagen flakes
JP3805654B2 (ja) 2001-08-29 2006-08-02 株式会社ネクスト 止血・癒着防止性のバイオポリマーの微細粒子
WO2003026709A1 (en) 2001-09-26 2003-04-03 Mbs Multination Business Services (G.B.) Ltd. Liquid mixture for use as a dressing spray
WO2003094983A1 (de) 2002-05-08 2003-11-20 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Resorbierbare pharmazeutische formulierung zur kontinuierlichen thrombinfreisetzung
AUPS242702A0 (en) * 2002-05-21 2002-06-13 Colltech Australia Limited Improved method for the extraction and purification of collagen
US8153591B2 (en) * 2003-08-26 2012-04-10 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
CN1554448A (zh) 2003-12-23 2004-12-15 张淑荣 壳聚糖明胶聚乙烯醇生物止血敷料
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
KR101186081B1 (ko) * 2004-03-17 2012-09-26 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 기능성 분체
EP1580229A1 (en) 2004-03-22 2005-09-28 Warner-Lambert Company Llc Biopolymer compositons and products thereof
JP4439517B2 (ja) 2004-05-13 2010-03-24 株式会社ネクスト21 経内視鏡手術に用いる止血と、癒着の防止装置
WO2006005340A1 (en) 2004-07-09 2006-01-19 Ferrosan A/S Haemostatic composition comprising hyaluronic acid
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN1709507A (zh) 2005-06-29 2005-12-21 肖春 外用复方止血镇痛消炎药
CN101272790A (zh) * 2005-09-22 2008-09-24 特罗比奥股份公司 稳定的蛋白酶组合物
JP5040234B2 (ja) 2006-09-26 2012-10-03 三菱電機株式会社 圧接型半導体装置
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
WO2009073854A1 (en) * 2007-12-06 2009-06-11 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
KR101541702B1 (ko) * 2008-03-03 2015-08-04 옴릭스 바이오파머슈티컬스 리미티드 활성 성분을 포함하는 젤라틴 스펀지, 이의 제조 방법 및 용도
FR2944706B1 (fr) 2009-04-28 2012-08-24 Biom Up Nouveaux materiaux en collagene et procedes d'obtention.
CN101757614B (zh) * 2010-02-22 2012-04-04 苏州汇涵医用科技发展有限公司 止血剂及其制备方法
CN101837143A (zh) * 2010-04-22 2010-09-22 胡堃 一种药物缓释止血组合物及制备方法
SMT201900467T1 (it) * 2011-04-27 2019-09-09 Biomup Composizioni emostatiche

Similar Documents

Publication Publication Date Title
JP2014512403A5 (cg-RX-API-DMAC7.html)
Li et al. Nanocellulose/gelatin composite cryogels for controlled drug release
ZA202209414B (en) Insect products and methods of manufacture and use thereof
JP2011513034A5 (cg-RX-API-DMAC7.html)
JP2016094516A5 (cg-RX-API-DMAC7.html)
IN2012DN03632A (cg-RX-API-DMAC7.html)
JP2011529463A5 (cg-RX-API-DMAC7.html)
JP2014223087A5 (cg-RX-API-DMAC7.html)
JP2016527890A5 (cg-RX-API-DMAC7.html)
JP2019526717A5 (cg-RX-API-DMAC7.html)
JP2013241609A5 (cg-RX-API-DMAC7.html)
WO2013127598A3 (de) Verwendung von pulvercellulose in kosmetika
NZ603411A (en) Pazopanib compositions and their use in treating ocular diseases
JP2016505044A5 (cg-RX-API-DMAC7.html)
JP2011518837A5 (cg-RX-API-DMAC7.html)
RU2015132974A (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
RU2016131243A (ru) Курительное изделие с материалом доставки жидкости
JP2016163597A5 (cg-RX-API-DMAC7.html)
NZ609356A (en) Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
BR112015007045A2 (pt) composição de cuidado pessoal
WO2010122258A3 (fr) Procede de fabrication de particules de poudre libre a base de polyamide impregnee d'au moins un agent cosmetique ou pharmaceutique, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique
WO2013160349A3 (en) Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide
JP2014076971A5 (cg-RX-API-DMAC7.html)
RU2014139542A (ru) Композиция для детоксикации организма
JP2018505805A5 (cg-RX-API-DMAC7.html)